JPMORGAN CHASE & CO - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 79 filers reported holding TREACE MED CONCEPTS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$4,569,727
-52.9%
348,568
-8.1%
0.00%0.0%
Q2 2023$9,697,710
+36.9%
379,113
+34.8%
0.00%0.0%
Q1 2023$7,084,000
+131646.3%
281,203
+20.2%
0.00%0.0%
Q4 2022$5,377
-99.9%
233,919
+2.0%
0.00%0.0%
Q3 2022$5,061,000
+56.3%
229,341
+1.5%
0.00%
Q2 2022$3,239,000
-27.2%
225,850
-4.0%
0.00%
-100.0%
Q1 2022$4,448,000
-9.5%
235,173
-10.8%
0.00%0.0%
Q4 2021$4,913,000
+110.2%
263,507
+203.2%
0.00%
Q3 2021$2,337,000
-29.4%
86,909
-17.9%
0.00%
Q2 2021$3,308,000105,8140.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,537,271$38,723,8564.26%
Millrace Asset Group, Inc. 72,595$1,8292.13%
Divisadero Street Capital Management, LP 175,000$4,408,2501.93%
Perceptive Advisors 2,442,250$61,520,2781.82%
SECTORAL ASSET MANAGEMENT INC 366,443$9,230,6991.77%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,234,8411.67%
EMERALD ADVISERS, LLC 1,363,453$34,345,3811.65%
FORMULA GROWTH LTD 124,900$3,146,2311.01%
Novo Holdings A/S 540,000$13,602,6000.90%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 755,379$19,027,9970.78%
View complete list of TREACE MED CONCEPTS INC shareholders